Firms

JIMCO Technology Fund

Dubai, AE

jimco.com

signal.nfx.com

goldi.ai

Technology venture investment brand within JIMCO, the Jameel family investment arm. Evergreen capital backs emerging technology directly and through other funds, across mobility, energy, semiconductors, fintech and AI/software. The official strategy primarily describes non-health sectors but also mentions digital health.

Founded: 2011
Type: Venture capital

Funds1

JIMCO Technology Fund evergreen vehicle——
Initially USD500m, with USD500m+ committed funds currently disclosed; one LP and evergreen additional-capital access. Amount omitted because current capital is a qualified standing commitment rather than a dated final close.

Team

Bruce Currie JIMCO Technology Fund, Managing Director JIMCO Life Sciences Fund	—— – —
Onur Aydin JIMCO Technology Fund, Managing Director JIMCO Technology Fund	—— – —
Sidhesh Kaul JIMCO Technology Fund, Chief Executive Officer, JIMCO	—— – —
Stephen D. Saint Leger JIMCO Technology Fund, Managing Director JIMCO Strategic Asset Fund	—— – —

Investments

team@apexlogos.ai12 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund size and investment stages | Metric | Finding and interpretation | Source/date | | --- | --- | --- | | Technology Fund capital | Initially **US$500 million**, one LP, structured as evergreen with potential additional capital. Current displayed metric is **US$500m+ committed funds**. This is a standing capital commitment disclosure, not a dated new closed-end fundraising close or target. | [Official Technology Fund](https://jimco.com/funds/technology/), undated; accessed 2026-10-06 | | Parent capital | JIMCO displays **US$2.5bn+ committed funds**; do not attribute this to Technology Fund or relabel it AUM. | [Corporate site](https://jimco.com/en/), undated; accessed 2026-10-06 | | Sibling Life Sciences capital | **US$400m+ committed funds**, founded 2020; separate from Technology Fund. | [Life Sciences Fund](https://jimco.com/en/funds/life-sciences/), undated; accessed 2026-10-06 | | Newer funds and checks | Searches through 2026-10-06 did not establish a newer numbered Technology Fund or dated increase. US$500m+ is the latest-known official capital metric checked; check sizes remain undisclosed. Investee round totals below are not JIMCO checks. | Official strategy and press-release archive; searches for JIMCO new funds in 2025/2026 | The stated mandate covers emerging non-health technologies, selected funds and promising early enterprises: fintech/insurtech, energy/water/renewables, AI/software/cloud, consumer/gaming, food/agritech and mobility. The same page also mentions digital health, which is a scope ambiguity to retain rather than erase. [Official strategy](https://jimco.com/funds/technology/) (undated; accessed 2026-10-06). Transaction evidence establishes broader historical stage coverage without proving an exclusive current mandate: pre-seed (Moonstep Games, US$2m, May 2025), seed (Vertical Semiconductor, US$11m, October 2025; Promake, US$4m, June 2026), Series A (Ever, US$31m, February 12, 2026), Series B (CFS, December 2021), Series C (Starship, 2025) and Series E (General Fusion, 2021). Sources: [Moonstep portfolio](https://jimco.com/en/portfolio/moonstep-games/), [Promake portfolio](https://jimco.com/en/portfolio/promake/) (both undated, accessed 2026-10-06), and dated sources below. Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | JIMCO Technology Fund evergreen vehicle | Undisclosed / unverified | Unknown |
team@apexlogos.ai12 hours ago
Match research 2026-10-06 / JIMCOTechnologyFund / sha256:c90a387793e5778ecaef0b79dd2eef0337398e623a7ee6544e7619e9c9ddcd11 / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. Ever's investment is verified by the [official announcement](https://jimco.com/en/news/jimco-invests-in-evers-31m-series-a-funding-round/) (2026-02-12), but AI auto retail/workflow software alone is insufficient to classify it with the physical deep-tech companies above. Promake is AI business-building software; fintech, earned-wage access and ordinary gaming investments likewise are not counted as deep tech merely because they use software or AI. ## Neurotechnology and adjacent investments **No verified neurotech investment found in the sources checked for JIMCO Technology Fund.** This is a fund-specific evidence finding, not a claim that the family or fund has never invested in neurotechnology. Kneu Health is a verified **adjacent neurological monitoring/digital biomarker** investment within sibling **Life Sciences Fund**. The company measures movement, speech and cognition through smartphones to monitor Parkinson's and dementia; it does not constitute evidence of a neural implant, BCI, direct neural recording or neuromodulation investment. Its October 9, 2025 company-issued announcement reports an oversubscribed **US$5.6m seed**, co-led by Oxford Science Enterprises and Cedars-Sinai, and names JIMCO generically. [Company release](https://www.prnewswire.com/news-releases/kneu-health-secures-5-6m-to-scale-next-generation-neurology-care-302579142.html). The [official JIMCO portfolio](https://jimco.com/en/portfolio/kneu-health/) explicitly states Life Sciences Fund participation in October 2025 (undated, accessed 2026-10-06), resolving the generic parent's attribution. This contradicts the baseline Technology Fund row. Searches for JIMCO neurotechnology also surfaced its LP relationship with Breakout Ventures Fund III; the official archive classifies this under Life Sciences. A third-party fund's neurotech portfolio is not a direct Technology Fund investment, and its US$114m fund size is not JIMCO capital or a JIMCO check. [Official archive](https://jimco.com/en/media-center/press-release/) (announcement listed April 7, 2026; accessed 2026-10-06). ## Concrete notes for a later Adex review 1. Scope the description to Technology Fund while retaining the parent relationship. Verify legal entity/address separately from Dubai business presence; do not automatically overwrite location. 2. Add qualified US$500m+ committed-capital/evergreen evidence and 2011 displayed founding year. Do not enter parent US$2.5bn+ as fund size, or infer checks from portfolio round totals. 3. Review Kneu Health attribution for reassignment to Life Sciences Fund; the official fund-specific source is explicit. Review Currie and Saint Leger roles for sibling-fund/parent placement. 4. Review Ever/Ever Cars for duplicate entity and same-round participation. Promake date can be refined from year-only to June 2026 using the official portfolio. 5. Review three Thndr rows and the 2022-02-08 US$15.7m record against a proper dated announcement; this focused research did not validate that pairing. Avoid retaining homepage/tag sources as decisive evidence. 6. Consider missing verified deep-tech investments from the table. Preserve publication-versus-transaction date discrepancies and the separate Joby holding vehicle. 7. General Fusion's 2025 release verifies parent participation only; do not silently convert it to fund-specific attribution without further evidence. Speero's source says pre-Series A, whereas baseline stage says Series A. FlexxPay likewise uses a pre-Series A source with Series A labeling; review stage normalization. 8. Baseline Rain, Figopara, Lean, Speero, FlexxPay and Bold Games are not all independently rechecked here. The portfolio and archive support several names, but this is not an exhaustive portfolio audit. Some official pages contain stale product timelines, so avoid copying forecasts as current facts. Research relied principally on directly read official pages and company-issued announcements; NFX access failed. Newer-fund searches and neurotech checks were focused rather than exhaustive. No mutations are authorized by this report.
team@apexlogos.ai12 hours ago
Match research 2026-10-06 / JIMCOTechnologyFund / sha256:c90a387793e5778ecaef0b79dd2eef0337398e623a7ee6544e7619e9c9ddcd11 / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # JIMCO Technology Fund - Exact Adex ID: `JIMCOTechnologyFund` - Canonical Adex URL: https://adex.page/firms/JIMCOTechnologyFund - Research date: 2026-10-06 - Scope: research only; no Adex or database changes. ## Summary and identity JIMCO Technology Fund is the technology venture investment brand within JIMCO, the Jameel family's global investment arm. It invests directly and through other funds. Verified holdings span fusion energy, power semiconductors, autonomous delivery and electric aviation. The important neurotechnology-related baseline claim, Kneu Health, belongs to **JIMCO Life Sciences Fund**, not this Technology Fund. The official fund page displays founding year 2011. The corporate site gives a St. Helier, Jersey contact address; the baseline Dubai location should not automatically be interpreted as legal headquarters. [Technology strategy](https://jimco.com/funds/technology/), [corporate site](https://jimco.com/en/) (undated, accessed 2026-10-06). ## Adex and NFX Signal starting evidence The exact-ID Adex snapshot, `data/research/_sources/JIMCOTechnologyFund.adex.json`, was retrieved 2026-10-06 from read-only MCP Search. Its description covers parent JIMCO across technology, life sciences and strategic assets. Founding year and minimum/maximum/sweet-spot check sizes are null. It lists Dubai and links the official site, NFX Signal and Goldi intelligence. Leadership includes Onur Aydin (Technology Fund managing director), Sidhesh Kaul (JIMCO CEO), Bruce Currie (Life Sciences Fund) and Stephen D. Saint Leger (Strategic Asset Fund). The latter two are sibling-fund roles, not evidence of Technology Fund management. The baseline has 14 investment participation rows: Ever, Ever Cars Co., Promake, Kneu Health, General Fusion, Lean Technologies, three Thndr entries, Figopara, Speero, Rain Financial Inc, FlexxPay and Bold Games. Ever/Ever Cars cite the same US$31m round/date and appear duplicated. Thndr rows mix a dated US$15.7m claim with undated entries and weak tag/homepage sources. Baseline claims are not independent verification. NFX starting URL: [JIMCO Technology Fund on Signal](https://signal.nfx.com/firms/jimco-technology-fund). Direct web access returned an inaccessible-page error on 2026-10-06. Searches for that URL, JIMCO Technology Fund, and Onur Aydin on Signal did not produce a readable firm/team profile. Therefore no Signal stage, check-size, portfolio or team claim was accepted; Signal was attempted directly, not successfully read or usefully search-index accessible. ## Fund size and investment stages | Metric | Finding and interpretation | Source/date | | --- | --- | --- | | Technology Fund capital | Initially **US$500 million**, one LP, structured as evergreen with potential additional capital. Current displayed metric is **US$500m+ committed funds**. This is a standing capital commitment disclosure, not a dated new closed-end fundraising close or target. | [Official Technology Fund](https://jimco.com/funds/technology/), undated; accessed 2026-10-06 | | Parent capital | JIMCO displays **US$2.5bn+ committed funds**; do not attribute this to Technology Fund or relabel it AUM. | [Corporate site](https://jimco.com/en/), undated; accessed 2026-10-06 | | Sibling Life Sciences capital | **US$400m+ committed funds**, founded 2020; separate from Technology Fund. | [Life Sciences Fund](https://jimco.com/en/funds/life-sciences/), undated; accessed 2026-10-06 | | Newer funds and checks | Searches through 2026-10-06 did not establish a newer numbered Technology Fund or dated increase. US$500m+ is the latest-known official capital metric checked; check sizes remain undisclosed. Investee round totals below are not JIMCO checks. | Official strategy and press-release archive; searches for JIMCO new funds in 2025/2026 | The stated mandate covers emerging non-health technologies, selected funds and promising early enterprises: fintech/insurtech, energy/water/renewables, AI/software/cloud, consumer/gaming, food/agritech and mobility. The same page also mentions digital health, which is a scope ambiguity to retain rather than erase. [Official strategy](https://jimco.com/funds/technology/) (undated; accessed 2026-10-06). Transaction evidence establishes broader historical stage coverage without proving an exclusive current mandate: pre-seed (Moonstep Games, US$2m, May 2025), seed (Vertical Semiconductor, US$11m, October 2025; Promake, US$4m, June 2026), Series A (Ever, US$31m, February 12, 2026), Series B (CFS, December 2021), Series C (Starship, 2025) and Series E (General Fusion, 2021). Sources: [Moonstep portfolio](https://jimco.com/en/portfolio/moonstep-games/), [Promake portfolio](https://jimco.com/en/portfolio/promake/) (both undated, accessed 2026-10-06), and dated sources below. ## Verified previous deep-tech investments Technology classification is the researcher's assessment from the engineering described. These are firm-attributed holdings, not partner investments at previous employers. All amounts are whole-round totals; individual JIMCO amounts were not disclosed. | Company | Technology rationale and firm attribution | Round/date and source | | --- | --- | --- | | Commonwealth Fusion Systems | MIT-origin fusion development using high-temperature superconducting magnets; explicit Technology Fund investment. | Over **US$1.8bn Series B**, December 1, 2021. [Official announcement](https://jimco.com/en/news/jimco-technology-fund-announces-major-participation-in-us-1-8-billion-series-b-funding-round-for-commonwealth-fusion-systems/) (published 2021-12-01). Historical milestones in this announcement are forecasts, not verified achievements. | | General Fusion | Magnetized Target Fusion reactor engineering; explicit Technology Fund participation in Series E. | **US$130m Series E**, body dateline December 6, 2021, page publication January 6, 2022. [Official announcement](https://jimco.com/en/news/jimco-technology-fund-confirms-major-participation-in-us-130-million-series-e-funding-round-for-general-fusion/). A later **US$22m/C$30m** financing on August 21, 2025 names **JIMCO parent**, not the fund: [company-issued release](https://www.globenewswire.com/news-release/2025/08/21/3137183/0/en/general-fusion-closes-oversubscribed-us-22-million-financing-welcomes-new-board-members.html). Keep that attribution distinction. | | Vertical Semiconductor | MIT-origin vertical gallium nitride power transistors; semiconductor device innovation to improve power delivery for AI infrastructure. Official portfolio explicitly attributes Technology Fund. | **US$11m seed**, October 2025 according to [official portfolio](https://jimco.com/en/portfolio/vertical-semiconductor/) (undated, accessed 2026-10-06); [official archive](https://jimco.com/en/media-center/press-release/) dates the announcement November 25, 2025. Round timing and publication date differ. | | Starship Technologies | Autonomous physical delivery robots, battery and navigation engineering. Explicit Technology Fund participation. | **US$50m Series C**; portfolio says October 2025, announcement published November 11, 2025. [Official release](https://jimco.com/en/news/jimco-participates-in-starships-us-50-million-series-c-funding-round/), [portfolio](https://jimco.com/en/portfolio/starship/) (undated, accessed 2026-10-06). | | Lilac Solutions | Patented ion-exchange technology and materials to recover lithium from brines without evaporation ponds. Explicit Technology Fund participation. | **Series B, September 2021**; amount not supplied by the checked page. [Official portfolio](https://jimco.com/en/portfolio/lilac-solutions/) (undated, accessed 2026-10-06). | | Joby Aviation | Electric vertical takeoff aircraft and associated aerospace propulsion/manufacturing. Official page attributes investment through Technology Fund, while noting a separate dedicated US investment vehicle holds the investment. | Page describes joining **US$820m Series C in 2020**, with a December 2020 stage label. Treat as the firm's historical claim; precise tranche timing needs investee confirmation. [Official portfolio](https://jimco.com/en/portfolio/joby-aviation/) (undated, accessed 2026-10-06). | | Rivian | Electric vehicle platform and manufacturing; official fund claims early/founding investor status. Round/date not established in this focused check. | [Official portfolio](https://jimco.com/en/portfolio/rivian/), [Technology Fund](https://jimco.com/funds/technology/) (undated, accessed 2026-10-06). | | Verne | Autonomous urban mobility/robotaxi ecosystem; engineering-based autonomy exposure. Official page explicitly attributes Technology Fund. | **US$100m Series A, April 2024**. [Official portfolio](https://jimco.com/en/portfolio/verne/) (undated, accessed 2026-10-06). |
team@apexlogos.ai23 days ago
MATCH

$31M2026-02-12	Ever Cars Co.	Eclipse, Ibex Investors, JIMCO Technology Fund
$31M2026-02-12	Ever	Eclipse, Ibex Investors, JIMCO Technology Fund
$50M2025-11-11	Starship Technologies	JIMCO Technology Fund
$11M2025-10-15	Vertical Semiconductor	Playground Global, Matt Hershenson, JIMCO Technology Fund
$22M2025-08-21	General Fusion	JIMCO Technology Fund
$67M2024-11-11	Lean Technologies	General Catalyst, Bain Capital Ventures, Duquesne Family Office, Arbor Ventures, JIMCO, JIMCO Technology Fund
$15M2022-02-08	Thndr	Y Combinator, Endeavor, Tiger Global Management, LLC, Prosus Ventures, BECO Capital, JIMCO, JIMCO Technology Fund
$130M2022-01-06	General Fusion	JIMCO Technology Fund
$11M2022	Figopara	JIMCO Technology Fund
$1.8B2021	Commonwealth Fusion Systems	Engine Ventures, Breakthrough Energy Ventures, Axel Springer, JIMCO Technology Fund
$15MUnknown date	Thndr	JIMCO Technology Fund
$6MUnknown date	Bold Games	JIMCO Technology Fund
$15MUnknown date	Thndr	JIMCO Technology Fund
$4M2026	Promake	JIMCO Technology Fund
$1M2021-07-12	Speero	JIMCO Technology Fund
$6M2021	Rain Financial Inc	JIMCO Technology Fund
$—Unknown date	Rivian	JIMCO Technology Fund
$100MUnknown date	Verne	JIMCO Technology Fund
$—Unknown date	Lilac Solutions	JIMCO Technology Fund
$3MUnknown date	FlexxPay	JIMCO Technology Fund

Funds1

Team

Co-investing

Investments